2022 MIT Bangkok Symposium - Startup Exchange Lightning Talks

Thanos Kosmidis has 20 years of experience in the technical and commercial divisions of high-tech companies in the USA and Europe. He is the cofounder & CEO of Care Across Ltd, and has grown the company to a leading position in the area of digital health in cancer, internationally. Mr Kosmidis is supporting cancer services at an institutional level. More specifically, he has served as an Assembly Member for the European Commission’s “Mission on Cancer”, and is a technology expert for the European Commission Initiative on Breast Cancer (ECIBC) and Colorectal Cancer (ECICC). Finally, Mr Kosmidis is an active member of the international Health 2.0 organisation, promoting the application of technology in healthcare, and a frequently invited speaker and presenter at international conferences in digital health.

Daniel Oliver is a co-founder and the CEO of Rejuvenate Bio, a startup out of George Church’s Lab at Harvard Medical School working on targeting the driver of age-related disease using novel gene therapies. Before Rejuvenate Bio, Daniel was awarded a Blavatnik Fellowship, during which he co-founded Voxel8. Voxel8 was named one of the top 9 innovations at CES and one of the top 50 most innovative companies by the MIT Technology Review. Daniel received his M.B.A. from Harvard Business School and has degrees in Mechanical Engineering and Business from the California Institute of Technology.

Dr. Hermano Igo Krebs is a Principal Research Scientist at MIT’s Mechanical Engineering Department and the Director of The77Lab (http://the77lab.mit.edu/). He holds affiliate positions as an Adjunct Professor at the University of Maryland School of Medicine, Department of Neurology, and as a Visiting Professor at Fujita Health University, Department of Physical Medicine and Rehabilitation (Japan), at Osaka University, Mechanical Science and Bioengineering Department (Japan), at Keio University, System Design Engineering Department (Japan) and at Loughborough University, The Wolfson School of Mechanical, Electrical, and Manufacturing Engineering (UK). He is a Fellow of the IEEE and received the 2015 IEEE-INABA Technical Award for Innovation leading to Production “for contributions to medical technology innovation and translation into commercial applications for Rehabilitation Robotics.” He was one of the founders and the Chairman of the Board of Directors of Interactive Motion Technologies from 1998 to 2016. He successfully sold it to Bionik Laboratories, a publicly traded company. He later founded 4Motion Robotics.

Ben Merewitz brings over 15 years of experience launching and managing industrial, biopharma, and medical technology businesses. Before Agile Devices, Ben spent most of his career advising management teams and launching products in high-tech sectors with heavy regulatory oversight. From building and scaling the first solar inverter market research practice to advising global publicly traded biopharma companies on multibillion-dollar decisions, Ben has consistently delivered strategic value to the C-suite, either as an external consultant or an internal advisor or Chief of Staff. As an operator, Ben has designed, built, and scaled products and services ranging from mobile aviation applications to APAC-focused biotech consultancies, consistently delivering 7+ figure revenue in the first year following launch. Ben has excelled in emerging/midsize companies (PureSense, PHOTON Consulting, Sentient Jet) and large multinational companies (Wellington Management, Alexion Pharmaceuticals, DRG, and Clarivate), with functional responsibilities primarily in corporate development, product management, and management consulting. Ben holds a BA in Psychology from Amherst College and an MBA in General Management from the MIT Sloan School of Management.